Skip to main content
Back to Norwest

Norwest's Therapeutics Portfolio

Browse 8 Therapeutics companies funded by Norwest. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
8
Total Funding in Therapeutics
$651.4M

Therapeutics Portfolio Companies (8)

Export
BiotechnologyHealth CareTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Philadelphia, United States
September 2022
$6.8M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

Redwood City, United States
June 2025
$80.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeuticsWellness

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

San Francisco, United States
May 2025
Secondary Market

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

San Diego, United States
April 2026
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceTherapeutics

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

San Carlos, United States
September 2025
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

SetPoint Medical provides a device-based therapy for rheumatoid arthritis.

Valencia, United States
August 2025
$115.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Redwood City, United States
December 2024
$161.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

30,000+ verified contacts

Explore Norwest's Full Portfolio

View all companies funded by Norwest across every industry and funding stage.

View Full Norwest Portfolio